Also listed on Confluence Life Sciences, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 9, 2033 · High confidence
20-year base term ends Dec 6, 2032
Held by Aclaris Therapeutics, Inc.
Filed Dec 6, 2012 as application 13/707,326 · Granted Jun 16, 2015
Base term plus 246 days of patent term adjustment (USPTO delay)
Today
2012
2033
Clock starts
Dec 6, 2012
Dec 6, 2012
Term ends
Aug 9, 2033
Aug 9, 2033
Granted
Jun 16, 2015
Jun 16, 2015
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
246
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
This patent's term runs 246 days past its 20-year base term on prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 6, 2012, when this application, 13/707,326, was filed | Dec 6, 2032 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +246 days, USPTO patent term adjustment record | Aug 9, 2033 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 9, 2033 | High confidence |
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Dec 6, 2012 Reel 29421, frame 187 | Selness, Shaun R.; Devadas, Balekudru; Hockerman, Susan L.; Monahan, Joseph B. | Confluence Life Sciences, Inc. | Assignment of Assignor's Interest |
| Nov 16, 2017 Reel 44477, frame 208 | Confluence Life Sciences, Inc. | Aclaris Life Sciences, Inc. | Merger |
| May 15, 2018 Reel 46153, frame 695 | Aclaris Life Sciences, Inc. | Aclaris Therapeutics, Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Aug 2033
Term ends Aug 9, 2033. Maintenance fees still fall due before then
Note
The 246 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
13
later US patents cite this one
That is above the median of utility patents granted in 2015 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.